Peter Thomas
20Patents
7h-index
13Co-inventors
62Inventor score
Filing activity: Mar 4, 1988 → Nov 18, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5811446A | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor | Emerging Cross-Sectional Technologies | 109 | Expired |
| US5972985A | Histidine containing nutriceutical compositions | Human Necessities | 51 | Expired |
| US4914021A | Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses | Emerging Cross-Sectional Technologies | 43 | Expired |
| US4921789A | Marker for colorectal carcinoma and methods of detecting the same | Emerging Cross-Sectional Technologies | 39 | Expired |
| US6329414A | Histidine containing nutriceutical | Human Necessities | 26 | Expired |
| US5854271A | Effective method for the amelioration and prevention of tissue and cellular damage | Human Necessities | 13 | Expired |
| US4996298A | Marker for colorectal carcinoma and methods of detecting the same | Emerging Cross-Sectional Technologies | 7 | Expired |
| US4892933A | Monoclonal antibody for colorectal carcinoma | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5741807A | Histidine compositions and methods for treating or preventing infectious and non-infectious diarrheas | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6150392A | Effective method for the amelioration and prevention of tissue and cellular damage | Human Necessities | 5 | Expired |
| US6207696A | Compositions and methods for the prophylaxis and treatment of dysmenorrhea, endometriosis, and pre-term labor, using histidine | Human Necessities | 5 | Expired |
| US5352691A | Effective treatment modality for adult respiratory distress syndrome using L-histidine | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6211221A | Dietary supplement containing histidine for alleviating dysmenorrhea, endometriosis, and pre-term labor | Human Necessities | 2 | Expired |
| US7656846B2 | PLC based wireless communications | Physics | 1 | Expired |
| US5658937A | Effective treatment modality for infectious diseases, pulmonary conditons and sequelae thereof | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5245017A | Method for isolating CEA-binding protein | Emerging Cross-Sectional Technologies | 0 | Expired |
| US5278290A | Binding protein for CEA and uses thereof | Emerging Cross-Sectional Technologies | 0 | Expired |
| US5281697A | CEA-binding protein and uses thereof | Emerging Cross-Sectional Technologies | 0 | Expired |
| US5204450A | Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses | Emerging Cross-Sectional Technologies | 0 | Expired |
| US5241052A | Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.